Smad anchor for receptor activation (SARA) is highly enriched on endocytic membranes via binding to phosphatidylinositol 3-phosphates through its FYVE (Fab1p-YOTB-Vps27p-EEA1) domain. SARA was originally identified as a protein that recruits non-phosphorylated SMAD2/3 to the activated TGFb receptors for phosphorylation, but later reports suggested a regulatory role in endocytic trafficking. Here we demonstrate that the ubiquitin ligase RNF11 is a SARA-interacting protein residing on early and late endosomes, as well as the fast recycling compartment. RNF11 and SARA interact with the ESCRT-0 subunits STAM2 and Eps15b, but only RNF11 associates with the core subunit Hrs. Both gain-and loss-of-function perturbation of RNF11 and SARA levels result in delayed degradation of epidermal growth factor (EGF)-activated EGF receptor (EGFR), while loss-of-function sustained/enhanced EGF-induced ERK1/2 phosphorylation. These findings suggest that RNF11 and SARA are functional components of the ESCRT-0 complexes. Moreover, SARA interacts with clathrin, the ESCRT-I subunit Tsg101 and ubiquitinated cargo exhibiting all the properties of Hrs concerning ESCRT-0 function, indicating that it could substitute Hrs in some ESCRT-0 complexes. These results suggest that RNF11 and SARA participate structurally and functionally in the ESCRT-dependent lysosomal degradation of receptors. As a consequence, the negative influence that perturbation of RNF11 and SARA levels exerts on the lysosomal degradation of EGFRs could underscore the reported overexpression of RNF11 in several cancers. In these cancers, deficient termination of the oncogenic signaling of mutated receptors, such as the EGFRs, through suboptimal lysosomal degradation could contribute to the process of malignant transformation.
INTRODUCTION
Signaling receptors undergo internalization via various endocytic entry routes, 1 clathrin-mediated endocytosis being the most known. Cargo, entering via these alternative routes, is transported to a series of intracellular compartments from where it is either recycled to the cell surface via recycling endosomes or directed to degradative compartments (late endosomes and lysosomes). Thus, the trafficking endomembrane system determines the strength and duration of signaling responses by controlling sorting events such as recycling and transport to the lysosomal compartment for ligand/receptor degradation, but also by recruiting downstream effectors of signaling complexes.
FYVE (Fab1p-YOTB-Vps27p-EEA1) domain-containing proteins bind to phosphatidylinositol 3-phosphate, which is highly enriched in endocytic membranes. As a consequence, FYVE domain-containing proteins are recruited to these compartments serving as regulators of endocytic membrane trafficking and signaling, albeit the latter function is less common. Early endosomal antigen (EEA1), hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) and Smad anchor for receptor activation (SARA) are three members of this family. SARA was originally identified as a protein that functions to recruit nonphosphorylated SMAD2/3 to the activated TGFb receptors for phosphorylation. Indeed, SARA binds SMAD2/3 proteins via a specific domain called SMAD-binding domain. 2, 3 Moreover, SARA binds and recruits protein phosphatase 1 to a specific domain downstream of SMAD-binding domain, thereby mediating TGFb receptor dephosphorylation. 4 In addition to the above-mentioned signaling properties, it has been reported that SARA also regulates trafficking. 5 Indeed, overexpression of SARA caused enlargement of early endosomes in a Rab5-dependent manner. Moreover, in SARA overexpressing cells, the number of transferrin (Tf) receptors on the cell surface was reduced as was Tf recycling, suggesting that Tf and Tf receptor remained associated in the expanded early endosomes. 5 Furthermore, SARA has been shown to regulate the vesicular targeting of rhodopsin-bearing axonemal vesicles in the lightsensing organelle in mammalian rods. 6 Because SARA appears to regulate both signaling and trafficking in the endocytic compartment, we have undertaken the task of identifying SARAinteracting proteins aimed at understanding in more depth the role of SARA in signaling and trafficking and the links thereof.
RESULTS

RNF11 is a SARA-interacting protein
To identify SARA-interacting proteins, a yeast two-hybrid (Y2H) screen was performed using a human placental cDNA library as prey and the carboxy-terminal region of SARA (SARAD1-664) as bait. Fifteen Y2H clones identified RNF11 RING-H2 E3 ligase (62-154 amino acid (aa)) as a SARA-interacting protein. 1 Indeed, glutathione S-transferase (GST)-RNF11 pulled down both FLAG-SARA and FLAG-SARAD1-664 ( Figure 1a) . Moreover, FLAG-SARA or FLAG-SARA D1-664 was detected in the immunoprecipitates of RNF11-HA (Figure 1b) , whereas myc-endofin, a protein with close homology to SARA, was not (Figure 1b) . In agreement, RNF11-HA was detected in FLAG-SARA and FLAG-SARAD1-664 immunoprecipitates (Figure 1c ). Though the interaction of the endogenous proteins was not feasible because of lack of specific antibodies against RNF11, these experiments clearly show that RNF11 is a SARA-interacting protein.
RNF11 localizes to the early and late endocytic, as well as the fast recycling compartments, in a SARA-independent manner RNF11 colocalized with EEA1 (33 ± 5.7%) (Figure 2A, a) , Rab5 (46±8%) (Figure 2A, b) and Rabenosyn-5 (34±7.5 %) (Figure 2A, c) , all known markers of early endosomes. [7] [8] [9] Moreover, RNF11 colocalized extensively (42 ± 8%) with Rab7 ( Figure 2A, d) , a late endocytic marker, 10 whereas colocalization with the lysosomal markers Lamp1 (Figure 2A Figure 3A) , a marker of the perinuclear recycling compartment, but exhibited extensive colocalization with Rab4 ( Figure 2B , h and Supplementary Figure 3A) and Tf ( Figure 2B, i) , markers of the fast recycling compartment and the fast recycling and perinuclear recycling compartment, respectively. Early endosomes in the cell periphery are mostly Rab5-and Rab4-positive and rarely contain Rab11, and as one moves to the center of the cell, the endosomes are mostly Rab4 and Rab11 positive. 11 It seems that RNF11 localizes to the peripheral Rab5/Rab4-positive compartment. To rule out perturbation of the endocytic compartment by transiently overexpressing Rab proteins, we further investigated RNF11 localization in A431 cell lines stably expressing either Rab11 or Rab4, almost at endogenous levels. 11 The results are comparable to those observed in experiments with transient transfection of human umbilical vein endothelial cells. RNF11 colocalizes extensively with Rab4a, but not with Rab11 (Supplementary Figure 3A) . Finally, RNF11 did not colocalize with Caveolin-1 ( Figure 2B, j) , a caveolar marker. 12, 13 Furthermore, green fluorescent protein (GFP)-tagged (Figure 3Aa -c) and endogenous SARA (Figure 3Ad -f) colocalized extensively (42±5 and 47±12%, respectively) with RNF11-mcherry in human umbilical vein endothelial cells. Moreover, EEA1, RNF11-mcherry and GFP-SARA, Figure 1 . SARA and RNF11 interact in vitro and in vivo: (a) GST pull-down assay: HEK293 cell lysates expressing either FLAG-SARA or FLAG-SARAD1-664 were incubated with GST-RNF11 or GST alone. The complexes were immunoblotted with an a-FLAG antibody. The lower panel in each case shows a ponceau stain of the GST proteins. (b, c) Co-immunoprecipitation of overexpressed proteins: (b) BHK (upper and lower panels) or HEK293 (middle panel) cells overexpressing RNF11-HA and FLAG-SARA, FLAG-SARAD1-664 or myc-endofin were lysed using 0.5% NP-40, and a-HA or rat IgG antibody immunoprecipitations were performed. Immunocomplexes were washed, analyzed by SDS-PAGE and immunoblotted with an a-HA antibody to confirm RNF11-HA immunoprecipitation and with a-FLAG or a-myc antibody to detect the coimmunoprecipitation of FLAG-SARA, FLAG-SARAD1-664 or myc-endofin. (c) BHK cells (upper) or HEK293 cells (lower) were transfected with FLAG-SARA and RNF11-HA or infected with an adenovirus expressing FLAG-SARAD1-664 and transfected with RNF11-HA, respectively. FLAG proteins were immunoprecipitated using a-FLAG-affinity conjugated agarose beads.
all colocalized on the same vesicles (early endosomes) ( Figure 3B ). Untagged RNF11 colocalized extensively with EEA1 on the endocytic compartment, excluding any influence of the tag on the localization ( Figure 3C ). Finally, RNF11 was clearly associated with vesicular structures (Figure 3Da -c) positive for EEA1 (data not shown), despite silencing of ZFYVE9 (SARA) gene ( Figure 3E ). In summary, RNF11 is localized to the early and late endocytic, as well as the fast recycling compartments. However, its interaction with SARA is not responsible for the endocytic recruitment of RNF11.
N-myristoylation and rapid endocytosis contribute to the accumulation of RNF11 in early endosomes RNF11 has several known domains, such as the PY motif (aa [37] [38] [39] [40] , the RING-H2 domain (aa 99-139) 14 and a myristoylation sequence at the N-terminus that may explain its endosomal localization. RNF11 mutants either in the PY motif or the RING-H2 domain (RNF11-HA Y40A and RNF11-HA C99A, respectively) exhibited a vesicular (punctate) staining, a property shared with RNF11 tagged at the C-terminus (RNF11-HA) (Figures 4Aa, d and e). On the contrary, N-terminal-tagged RNF11 (HA-RNF11) and a myristoylation-preventing RNF11 mutant (RNF11-HA G2A) localized to the cytosol and nucleus (Figure 4Ab and c), suggesting that N-myristoylation is a prerequisite for the endosomal localization of RNF11. Because we did not detect RNF11 at the plasma membrane, despite the membrane anchoring myristoylation, we assumed that RNF11 is rapidly trafficked to early and late endosomes. Indeed, blocking internalization by overexpressing a dominant-negative form of Dynamin I (K44A) trapped RNF11-mcherry at the cell Figure 2 . RNF11 localizes to the early, late and fast recycling endocytic compartments: (A, B) human umbilical vein endothelial (HUVE) cells were transiently transfected with RNF11-mcherry alone (a, e) or together with GFP-Rab5a (b), myc-Rabenosyn-5 (c), GFP-Rab7 (d), GFP-Rab11 (g), GFP-Rab4a (h) and GFP-Caveolin-1 (j). In the case of EEA1 (a), Lamp1 (e) and CD63 (f), a-EEA1, a-Lamp1 and a-CD63 antibodies were used, whereas myc-Rabenosyn-5 (c) was visualized using the 9E10 antibody. In panels (f ) and (i), HUVE cells were infected with RNF11-GFP adenovirus, and in panel (i), tritc-Tf (50 mg/ml) was added at 371C for 30 min. Merged images and zoomed inserts are shown in each case. Scale bars, 10 mm.
surface (Figure 4Ba and c) . The same was true, when we inhibited endocytosis using two Dynamin II-specific small interfering RNAs (siRNAs) (Figure 4Cb and c). These data indicate that, following synthesis, RNF11 reaches the plasma membrane accumulating in the endocytic compartment via rapid endocytosis.
Mapping the domains responsible for the RNF11-SARA interaction We generated overlapping carboxy-terminal constructs of SARA (Figure 5a ), covering the Y2H bait sequence, and tested their interaction with GST-RNF11. SARA-1 (667-926 aa) interacted with GST-RNF11, whereas SARA-2 (906-1204 aa) and SARA-3 (1170-1323 aa) exhibited no interaction (Figure 5b ). Likewise, deletion mutants of RNF11 ( Figure 5c ) indicated that GST-RNF11 and GST-RNF11D1-58, but not GST-RNF11D59-95, GST-RNF11D96-154 and GST-RNF11 59-95, interacted with SARAD1-664 ( Figure 5d ). These results indicate that both aa 59-95 and RING-H2 domains of RNF11 are required for binding to SARA-1. Indeed, FLAG-SARA D1-664 did not co-immunoprecipitate RNF11-HA D59-95 or RNF11-HA C99A, a mutant of RNF11 in which a cysteine in the RING-H2 domain has been mutated to alanine (Figure 5e ).
The RNF11-SARA complex is associated with the ESCRT-0 core proteins RNF11 binds both homologous to the E6-AP carboxyl terminus (HECT)-type E3 ubiquitin ligases (Nedd4, AIP4, Smurf1 and Smurf2) and deubiquitinating enzymes, such as AMSH, 14, 15 suggesting that it may participate in lysosomal targeting of cargo. Interestingly, STAM2 and Eps15, two subunits of the ESCRT-0 machinery 16 that participates in the lysosomal trafficking of ubiquitinated cargos, have been suggested to be putative RNF11-interacting proteins in a Y2H screen. 15, 17 Indeed, GST-RNF11 specifically pulled down myc-STAM2 ( Figure 6A , left upper panel), and myc-STAM2 was specifically co-immunoprecipitated by RNF11-HA ( Figure 6A , right upper panel). In agreement, overexpressed RNF11-HA and myc-STAM2 colocalize on punctate structures in BHK cells ( Figure 6A , lower panel). The same was true for SARA, myc-STAM2 was detected in the a-FLAG immunoprecipitates of BHK cells overexpressing myc-STAM2 and FLAG-SARA ( Figure 6B ). Interestingly, only Eps15b was co-immunoprecipitated by RNF11-HA, but not Eps15 ( Figure 6C ).
From these experiments, it was evident that RNF11 interacted with SARA, STAM2, and Eps15b and SARA interacted with RNF11 and STAM2. This data indicated that RNF11 and SARA might be in complex with ESCRT-0. Indeed, FLAG-SARA, myc-STAM2 and mycEps15b were all co-immunoprecipitated by RNF11-HA ( Figure 6D ). On the other hand, Eps15b and STAM2 also exist in complex with Hrs in ESCRT-0 machinery. RNF11-HA interacted with Hrs when both proteins were overexpressed in BHK cells ( Figure 6E ), but, despite our attempts, SARA and Hrs did not co-immunoprecipitate ( Figure 6E ).
Hrs is capable of interacting with clathrin 18 and the ESCRT-I complex via the TSG101 subunit; 19 properties that we show here are shared by SARA. Indeed, analysis of the SARA sequence suggested the presence of a potential clathrin box at aa 637-641 (LLYMD) and FLAG-SARA interacted with GST-clathrin (Figure 7a ) in pull-down assays. Also, when GFP-SARA was overexpressed in HeLa cells stably expressing approximately endogenous levels of mcherry-TSG101, GFP-SARA was detected in the immunoprecipitates of mcherry-TSG101 (Figure 7b ). Likewise, mcherry-Tsg101 was readily detected in the immunoprecipitates of GFP-SARA (Figure 7c ). Moreover, ubiquitin-conjugated beads pulled down RNF11-GFP from cell lysates (Figure 7d) , and GFP-SARA (Figure 7e ), suggesting that RNF11 and SARA might sequester ubiquitinated cargo. Taken together, these results suggest that SARA exhibits all the properties of Hrs concerning ESCRT-0 function, indicating that it could substitute Hrs in some ESCRT-0 complexes.
RNF11 and SARA participate in the sorting functions of ESCRT-0 machinery on epidermal growth factor receptor (EGFR) trafficking One of the sorting cargoes destined for lysosomal degradation by the ESCRT machinery is EGFR (reviewed in Raiborg and Stenmark 16 ). Indeed, RNF11 has been shown to influence the levels of EGFR in cancer cells. 20 We investigated the effect of RNF11 gene silencing on the EGF-induced degradation of EGFR. At steady state, EGFR levels were higher in the RNF11-and SARA-silenced cells (Figure 8a , left panel and Supplementary Figure 1A) . The rate of degradation was significantly slower in the RNF11-silenced compared with the control cells (Figure 8a (Figure 8d, lower panel) . Also, RNF11 gene silencing appeared to lead to sustained ERK1/2 activation (Figure 8d, upper panel) , reminiscent to the enhancement of ERK1/2 activation observed during Hrs depletion. 21 Overexpression of RNF11 and SARA did not lead to visible enhancement of ERK1/2 phosphorylation (Figure 8e ).
Enhanced recycling of endocytosed EGF and its receptor EGFR, 22 which is associated with inhibition of lysosomal receptor trafficking imposed by Hrs or Eps15b depletion, 23 has been suggested to be responsible for the enhanced ERK1/2 activation. Thus, we investigated the effect of SARA and RNF11 depletion on EGF trafficking. Neither SARA nor RNF11 depletion affected the internalization rate of iodinated EGF (Figure 8f, left panel) . 24 However, although depletion of SARA, RNF11 and Hrs decreased degradation of iodinated EGF (Figure 8f, middle panel) , only RNF11 and Hrs depletion led to increased EGF recycling (Figure 8f , right panel). Depletion of SARA did not change the rate of iodinated EGF recycling (Figure 8f, right panel) .
To obtain a visual confirmation of the effects of SARA depletion, we investigated the fate of rhodamine-labeled EGF (Rh-EGF) using confocal microscopy after SARA depletion. In the first 10 min, the amount of Rh-EGF internalized in HeLa cells was similar in the presence or depletion of SARA (Supplementary Figure 2A) . However, at later time points (30, 60 or 120 min), the intensity of Rh-EGF fluorescence per cell was clearly higher in SARAdepleted cells (Supplementary Figure 2A) . Colocalization of Rh-EGF with EEA1 revealed that at 30 min, the percentage of Rh-EGF that is localized in early endosomes is clearly increased in SARAdepleted cells (Supplementary Figure 2B) . These results suggest that RNF11 depletion delays EGF/EGFR processing in a compartment compatible with recycling that leads to sustained ERK1/2 activation, whereas SARA depletion seems to 'trap' EGFR in a compartment (positive for EEA1), where recycling cannot occur, but the activity of the EGF/EGFR complex is increased/sustained.
In an attempt to further define the domains of RNF11 involved in degradation of EGFR, we analyzed the effect of RNF11 mutants on the fate of Rh-EGF after 1 and 2 h following internalization. We compared the effects of GFP alone, RNF11-GFP, RNF11-GFP D59-95, RNF11-GFP C99A and RNF11-GFP Y40A. RNF11-GFP delays the depletion of Rh-EGF as expected, whereas both Figure 5 . Mapping the RNF11-SARA interaction domains: (a) Domain organization of SARA and constructs used to test RNF11 interaction. (b) HEK293 cell lysates expressing either HA-SARA-1, HA-SARA-2 or HA-SARA-3 were incubated with GST-RNF11 or GST protein alone. The complexes were immunoblotted with an a-HA antibody. (c) Schematic representation of RNF11 with all known or predicted modular domains or motifs, and constructs generated to test its interaction with SARA. (d) HEK293 cell lysates expressing FLAG-SARAD1-664 were incubated in GST protein alone, GST-RNF11 wild-type or GST-RNF11 truncated proteins as outlined in Figure 5c . The complexes were immunoblotted with an a-FLAG antibody. (e) HEK293 cells infected with FLAG-SARAD1-664-expressing or control adenoviruses were transfected with the indicated RNF11 constructs. Cell lysates were subjected to immunoprecipitation using a-FLAG-affinity conjugated agarose beads. The lower panel in b and d shows a ponceau stain of the GST proteins.
RNF11 D59-95 and RNF11-C99A have a similar effect as the GFP control protein, suggesting that the domains deleted or mutated in these mutants are important for the effect. The PY motif mutant of RNF11 has a similar effect as RNF11 wild-type protein, and we conclude that the PY motif has no regulatory role in this process (Supplementary Figure 4) .
DISCUSSION
We have identified RNF11 as a SARA-interacting protein by means of an Y2H screen and biochemical validation. RNF11 is a modular 154-aa-containing RING-H2 E3 ligase, harboring a PY motif and a RING-H2 domain. RNF11 interacts with ubiquitin E3 ligases (see below) and numerous other proteins 14 exerting diverse functions from inhibiting TNF-induced NF-kB signaling 25 to being proposed as a candidate gene for Parkinson's disease. 26 RNF11 interacts, via its PY motif, with WW domain-containing proteins, such as the HECT-type E3 ligases Nedd4, AIP4, Smurf1 and Smurf2, 27 as well as with Cullin, the core protein in the multi-subunit Skp, Cullin, F-box (SCF) E3 ubiquitin ligase complex.
14 These E3 ligases ubiquitinate various substrates, but also RNF11 itself. 28 RNF11 is known to interact also with E2-conjugating enzymes acting as adaptor for activation of E3 ligases. 28 Interestingly, RNF11 interacts with AMSH, an ubiquitin isopeptidase (a de-ubiquitination enzyme, DUB), recruiting AMSH to Smurf2 for ubiquitination and degradation. 15 The simultaneous interaction of RNF11 with ubiquitinating and deubiquitinating enzymes indicate that RNF11 may have a role as an ubiquitination fine tuner. These properties rendered RNF11 as an attractive molecule for investigating the significance of its association with SARA in membrane trafficking and signaling.
The interaction of RNF11 with SARA implied that RNF11, or at least a percentage of it, should be localized to the early endocytic compartment. Indeed, we found extensive colocalization of RNF11 Figure 6 . RNF11 and SARA associate with the ESCRT-0: (A) RNF11 and STAM2 interact in vitro and in vivo: (upper left) myc-STAM2 was overexpressed in BHK cells using the T7 RNA polymerase vaccinia virus system, either in the presence or in the absence of EGF (100 ng/ml). Cell lysates were incubated with GST-RNF11 or GST protein alone immobilized on GST beads. The complexes were immunoblotted with an a-myc antibody. RNF11-HA and myc-STAM2 (upper right) were overexpressed in BHK cells, and cell lysates were subjected to immunoprecipitation with a-HA or rat IgG antibody. The complexes were immunoblotted with an a-myc antibody. BHK cells overexpressing RNF11-HA and myc-STAM2 (lower) were fixed and processed for indirect immunofluorescence with a-HA and 9E10 antibodies. Scale bar, 10 mm. (B) SARA and STAM2 co-immunoprecipitate: FLAG-SARA and myc-STAM2 were overexpressed in BHK cells using the T7 RNA polymerase vaccinia virus system, and cell lysates were subjected to immunoprecipitation with a-FLAG or mouse IgG antibodies. The complexes were immunoblotted with an a-myc and an a-FLAG antibody. (C) RNF11 interacts with Eps15b, but not with Eps15, in vivo: RNF11-HA and myc-Eps15 or myc-Eps15b were overexpressed in BHK cells, and cell lysates were subjected to immunoprecipitation with a-HA or rat IgG antibody followed by immunoblot using an a-myc and an a-HA antibody. (D) SARA, Eps15b, STAM2 and RNF11 are in the same complex: RNF11-HA, myc-Eps15b, myc-STAM2 and FLAG-SARA were overexpressed in BHK cells, and cell lysates were subjected to immunoprecipitation with a-HA or rat IgG antibody. After probing with 9E10 or with a-FLAG antibodies, myc-Eps15b, myc-STAM2 and FLAG-SARA were detected only at the a-HA and not at the IgG control immunoprecipitates. (E) RNF11 interacts but SARA does not interact with Hrs: myc-Hrs and FLAG-SARA or RNF11-HA were overexpressed in BHK cells, and cell lysates were subjected to immunoprecipitation with a-FLAG or a-HA and control IgG antibodies, respectively.
with SARA and early endosomal-specific markers. Moreover, a considerable proportion of RNF11 resides on late endosomes and on the Rab4-positive recycling compartment. These data are in agreement with a very recent report 29 fully establishing the endocytic localization of RNF11.
The association of RNF11 with SARA was not, however, responsible for the endocytic localization of RNF11. The PY motif and RING-H2 domain were excluded also from being responsible for the endosomal localization of RNF11. However, a C-terminal HAtagged RNF11 mutant, in which the critical for acylation glycine at position 2 30 is mutated to alanine (RNF11-HA G2A), did not localize to vesicular structures, instead it exhibited diffuse cytoplasmic and nuclear distribution, confirming recent data on RNF11 myristoylation. 29 Interestingly, inhibition of endocytosis, significantly, shifted RNF11 localization towards the plasma membrane, suggesting that RNF11, reaching the plasma membrane, undergoes rapid endocytosis and sequestration in the endocytic compartment through unidentified protein/lipid interactions.
In this study, we show that RNF11 interacts with SARA, STAM2 and Eps15b, whereas SARA is associated with RNF11 and STAM2.
In fact, FLAG-SARA, myc-STAM2 and myc-Eps15b were all coimmunoprecipitated by RNF11-HA. This data indicated that RNF11 and SARA might be in complex with ESCRT-0. In confirmation, RNF11 co-immmunoprecipitated Hrs and implied that the wellcharacterized ESCRT-0 complex, comprising Hrs and STAM2, might include also RNF11. However, we were unable to detect any coimmunoprecipitation of SARA with Hrs, a result suggesting that the two FYVE domain proteins, Hrs and SARA, do not exist in the same complex. Taken together, these results indicated that SARA might participate in an alternative complex with RNF11, STAM2 and Eps15b distinct from that formed by Hrs with the same proteins.
In this context, we have additionally shown that SARA interacts with the TSG101 subunit of ESCRT-I, suggesting that it is capable of recruiting ESCRT-I. Indeed, SARA harbors a PTPP sequence compatible with the P(S/T)XP consensus sequence that binds the ubiquitin E2 variant (UEV) domain of TSG101. 31, 32 Moreover, SARA interacted with clathrin, perhaps, through the LLYMD sequence (aa 637-641). 18 Thus, SARA exhibits all the key properties of Hrs with regard to ESCRT-0 assembly. These are (i) binding the endosomal lipid phosphatidylinositol 3-phosphate through its FYVE zinc-finger domain, (ii) binding to STAM2 and Eps15b, (iii) binding the TSG101 subunit to recruit the ESCRT-I complex and (iv) binding to clathrin to increase the concentration of ESCRT-0 in restricted clathrin coats on endosomal membranes. Also, despite the lack of an ubiquitin interacting motif (UIM), GFP-SARA was pulled down by ubiquitin, suggesting that SARA is capable of sequestering ubiquitinated cargo, probably via its associated proteins. It should be noted that several cargos, such as IL-2Rb, are sorted by Hrs from early to late endosomes, independently of UIM-ubiquitin binding. 33 In these cargos, Hrs recognizes a hydrophobic amino-acid cluster, which is utilized as an ubiquitin-independent sorting signal. 34 Therefore, SARA exhibits all the structural requirements to form an alternative to Hrs ESCRT-0 complex. Indeed, not only do the Hrs-and TSG101-independent pathways exist 35, 36 but also totally ESCRT-independent mechanisms of multivesicular endosome biogenesis have been predicted to occur. 37 The ESCRT-0 complex consists of Hrs, STAM2 and Eps15b. Interestingly, overexpression or depletion of Hrs and Eps15b, two key components of ESCRT-0, leads to impaired degradation of internalized EGFR, 18, 23, 38, 39 exhibiting the characteristic bellshaped titration curve of scaffold proteins. 40, 41 Here we show that, similarly to Hrs and Eps15b, depletion and overexpression of RNF11 and SARA impaired EGF-induced EGFR degradation, strongly suggesting that both RNF11 and SARA have an important role in lysosomal sorting of EGFR.
Depletion of Hrs and Eps15b is associated with enhanced recycling of endocytosed EGF and its receptor EGFR, 22, 23 apparently because the ESCRT-0 complex fails to recognize and cluster 42 ubiquitinated cargos to prevent their recycling to the plasma membrane. Depletion of components of ESCRT-II and ESCRT-III, when the cargo is already trapped in multivesicular endosomes, does not lead to recycling of the cargo. 22, 43 Depletion of RNF11 enhanced EGF recycling, indicating that RNF11 may have a key role in maintaining EGFR ubiquitinated, facilitating cargo recognition and clustering. 42 Apparently, the RNF11-associated proteins (HECT E3 ligases, SCF E3 ligases and E2-conjugating enzymes), as well as their ability to degrade AMSH (see above), contribute to this activity.
Depletion of SARA does not increase EGF recycling, suggesting an effect at a later stage of the trafficking route. In this respect, depletion of SARA exhibits the same effect as depletion of Vps22/ EAP30 and Vps24/CHMP3, subunits of ESCRT-II and ESCRT-III, respectively. 22, 43 However, there is one important difference. Depletion of SARA enhances ERK1/2 phosphorylation, whereas depletion of Vps22 and Vps24 is without effect on ERK signaling. 22, 43 Because depletion of Hrs (ESCRT-0) and TSG101 (ESCRT-I) enhances ERK1/2 activation, 21, 43 it seems that termination of EGF signaling occurs before ESCRT-I and -II engagement. Tracing of Rh-EGF in SARA-depleted HeLa cells by confocal microscopy revealed that trafficking of this labeled ligand is delayed in an EEA1-positive early endosomal compartment. Because, ESCRT-I and II localize to the necks of membrane buds, inducing bud formation and confining cargo, 42 it appears that SARA depletion delays the EGF/EGFR complex in the endosomal compartment just before bud formation, late enough to escape recycling, but still before termination of EGF signaling.
In conclusion, RNF11 interacts with SARA, and both appear to be structurally and functionally associated with the ESCRT-0 complex that regulates lysosomal degradation of EGFRs, a process that has a major role in termination of EGFR signaling. 44 Thus, perturbation of RNF11 and SARA levels decrease EGFR degradation, thereby generating conditions that may favor their mitogenic signaling. This could be particularly important for mutated EGFR receptors that are constitutively active in certain cancers (reviewed in Mimeault and Batra 45 ). Indeed, RNF11 is overexpressed in kidney, prostate and invasive breast cancer tumors being particularly high in the latter. 27 
MATERIALS AND METHODS
Cell culture and transfection
Human umbilical vein endothelial cells were isolated, cultured and transfected as previously described. 46, 47 HeLa and NIH3T3 cells were maintained in Dulbecco's modified Eagle culture medium supplemented with 10% fetal calf serum and transfected with Effectene (Qiagen, Hilden, Germany). HEK293 were maintained in RPMI1640 culture medium supplemented with 10% fetal calf serum and transfected with Fugene 6 (Roche, Basel, Switzerland). Culture of BHK cells and overexpression of proteins using the T7 RNA polymerase vaccinia virus system were previous described. 48 NIH3T3 cells stably lacking SARA were selected and cultured in medium containing 4.5 mg/ml puromycin (Sigma-Aldrich, St Louis, MO, USA) and were transfected with Effectene (Qiagen). HeLa cells stably expressing mcherry-TSG101 were kindly provided by Juan Martin-Serrano, King's College, London, UK, and cultured in medium containing 200 ng/ml puromycin. A431 cells stably expressing GFP-Rab4 or GFP-Rab11 were kindly provided by Marino Zerial (MPI-CBG, Dresden, Germany), 11 were maintained in medium supplemented with 0.5 mg/ml G418 and transfected with Effectene (Qiagen). The siRNAs (20 nM) were transfected using RNAimax (Invitrogen, Carlsbad, CA, USA). Conjugated Tf (50 mg/ml) (Molecular Probes, Eugene, OR, USA) was internalized for 30 min at 37 o C. All media (Invitrogen) were supplemented with 100 U/ml penicillin, 100 mg/ ml streptomycin and 2 mM glutamine.
Antibodies and recombinant proteins hEGF was purchased from ImmunoTools (GmbH, Friesoythe, Germany) and Tetramethylrhodamine-EGF from Molecular Probes. a-EEA1 rabbit polyclonal antibody was kindly provided by Marino Zerial, and an a-mcherry mouse monoclonal antibody was kindly provided by Patrick Keller (MPI-CBG). Mouse a-Lamp1 and a-CD63 were purchased from DSHB (Iowa City, IA, USA), mouse a-EEA1 and mouse a-Dynamin from Transduction Laboratories (Franklin Lakes, NJ, USA), mouse a-FLAG M2 from SigmaAldrich, rat a-HA and mouse a-GFP from Roche, rabbit a-HA from Babco (Richmond, CA, USA), goat a-SARA, rabbit a-SARA and goat a-EGFR from Santa Cruz Biotechnology (Santa Cruz, CA, USA), mouse a-actin from Chemicon (Billerica, MA, USA) and rabbit a-pERK1/2 from Cell Signaling (Danvers, MA, USA). A rabbit polyclonal antibody recognizing only overexpressed RNF11 was generated using GST-RNF11 recombinant protein and purified by western strip technique.
Expression plasmids, siRNAs and recombinant adenoviruses
The hRNF11 full-length cDNA clone IRATp970A1119D was purchased from imaGenes (Source BioScience UK Ltd., Nottingham, UK). pcDNA3.1 RNF11-HA Y40A, pcDNA3.1 RNF11-HA C99A, pcDNA3.1 RNF11, pcDNA3.1 RNF11-HA, pcDNA3 HA-RNF11, pcDNA3.1 RNF11-HA G2A, pcDNA3.1 RNF11-HA D59-95, pEGFP-N1-RNF11, pcDNA3 RNF11-mcherry, pGEM-RNF11-HA, pGEX-6P-1 RNF11, pGEX-6P-1 RNF11D59-95, pGEX-6P-1 RNF11D1-58, pGEX-6P-1 RNF11D96-154 and pGEX-6P-1 RNF11 59-95 were generated by PCR amplification as outlined in Supplementary Information (Supplementary Table 1 ). All constructs were sequenced (MWG-Biotech, Ebersberg, Germany). RNF11-Y40A and RNF11-C99A cDNA were provided by Edward Harhaj. pcDNA3 HA-SARA-1, pcDNA3 HA-SARA-2 and pcDNA3 HA-SARA-3 were previously described. 49 The numbering of SARA is based on Gene Bank sequence AF 104304. pGEM myc-STAM2, pcDNA3 mycEps15 and pcDNA3 myc-Eps15b were as previously described, 23, 39 and pcDNA3 myc-endofin, pEGFP-C2-SARA and pGEM-FLAG-SARA were generated by standard cloning techniques. pcDNA3 myc-Hrs was as described, 50 whereas GST-clathrin-TD 1-579 was provided by Stuart Kornfeld, Washington University of Medicine, USA. PCB-HA-Dynamin-I K44A, PCB-HA-Dynamin-I and pcDNA3 myc-Rabenosyn-5 were provided by Savvas Christoforidis, UOI, Greece. pEGFP-C3-Rab11, pEGFP-C3-Rab5a,
